[1]
|
[1]Tomasoni, D., Adamo, M., Lombardi, C.M. and Metra, M. (2019) Highlights in Heart Failure. ESC Heart Fail, 6, 1105-1127. https://doi.org/10.1002/ehf2.12555
|
[2]
|
Murphy, S.P., Ibrahim, N.E. and Januzzi, J.J. (2020) Heart Failure with Reduced Ejection Fraction: A Review. JAMA, 324, 488-504. https://doi.org/10.1001/jama.2020.10262
|
[3]
|
Divorty, N., Mackenzie, A.E., Nicklin, S.A. and Milligan, G. (2015) G Protein-Coupled Receptor 35: An Emerging Target in Inflammatory and Cardiovascular Disease. Frontiers in Pharmacology, 6, Article No. 41.
https://doi.org/10.3389/fphar.2015.00041
|
[4]
|
Alexander, S.P., Christopoulos, A., Davenport, A.P., Kelly, E., Marrion, N.V., Peters, J.A, et al. (2017) The Concise Guide to Pharmacology 2017/18: G Protein-Coupled Receptors. British Journal of Pharmacology, 174, S17-S129.
https://doi.org/10.1111/bph.13878
|
[5]
|
Zhao, M., Wang, Z., Yang, M., Ding, Y., Zhao, M., Wu, H., et al. (2021) The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases. Clinical Reviews in Allergy & Immunology, 60, 220-243.
https://doi.org/10.1007/s12016-020-08829-y
|
[6]
|
Slosky, L.M., Caron, M.G. and Barak, L.S. (2021) Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery. Trends in Pharmacological Sciences, 42, 283-299. https://doi.org/10.1016/j.tips.2020.12.005
|
[7]
|
Rask-Andersen, M., Masuram, S. and Schioth, H.B. (2014) The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication. Annual Review of Pharmacology and Toxicology, 54, 9-26. https://doi.org/10.1146/annurev-pharmtox-011613-135943
|
[8]
|
Sriram, K. and Insel, P.A. (2018) G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? Molecular Pharmacology, 93, 251-258. https://doi.org/10.1124/mol.117.111062
|
[9]
|
Wang, X., Kim, S.H., Ablonczy, Z., Crouch, R.K. and Knapp, D.R. (2004) Probing Rhodopsin-Transducin Interactions by Surface Modification and Mass Spectrometry. Biochemistry, 43, 11153-11162. https://doi.org/10.1021/bi049642f
|
[10]
|
Woo, A.Y. and Xiao, R.P. (2012) Beta-Adrenergic Receptor Subtype Signaling in Heart: From Bench to Bedside. Acta Pharmacologica Sinica, 33, 335-341. https://doi.org/10.1038/aps.2011.201
|
[11]
|
Lagerstrom, M.C. and Schioth, H.B. (2008) Structural Diversity of G Protein-Coupled Receptors and Significance for Drug Discovery. Nature Reviews Drug Discovery, 7, 339-357. https://doi.org/10.1038/nrd2518
|
[12]
|
O’Dowd, B.F., Nguyen, T., Jung, B.P., Marchese, A., Cheng, R., Heng, H.H., et al. (1997) Cloning and Chromosomal Mapping of Four Putative Novel Human G-Protein-Coupled Receptor Genes. Gene, 187, 75-81.
https://doi.org/10.1016/S0378-1119(96)00722-6
|
[13]
|
Adams, J.W., Wang, J., Davis, J.R., Liaw, C., Gaidarov, I., Gatlin, J., et al. (2008) Myocardial Expression, Signaling, and Function of GPR22: A Protective Role for an Orphan G Protein-Coupled Receptor. American Journal of Physiology: Heart and Circulatory Physiology, 295, H509-H521. https://doi.org/10.1152/ajpheart.00368.2008
|
[14]
|
Rathjens, F.S., Blenkle, A., Iyer, L.M., Renger, A., Syeda, F., Noack, C., et al. (2021) Preclinical Evidence for the Therapeutic Value of TBX5 Normalization in Arrhythmia Control. Cardiovascular Research, 117, 1908-1922.
https://doi.org/10.1093/cvr/cvaa239
|
[15]
|
Foata, F., Sprenger, N., Rochat, F. and Damak, S. (2020) Activation of the G-Protein Coupled Receptor GPR35 by Human Milk Oligosaccharides through Different Pathways. Scientific Reports, 10, Article No. 16117.
https://doi.org/10.1038/s41598-020-73008-0
|
[16]
|
Quon, T., Lin, L.C., Ganguly, A., Tobin, A.B. and Milligan, G. (2020) Therapeutic Opportunities and Challenges in Targeting the Orphan G Protein-Coupled Receptor GPR35. ACS Pharmacology & Translational Science, 3, 801-812.
https://doi.org/10.1021/acsptsci.0c00079
|
[17]
|
Min, K.D., Asakura, M., Liao, Y., Nakamaru, K.,. Okazaki, H., Takahashi, T., et al. (2010) Identification of Genes Related to Heart Failure Using Global Gene Expression Profiling of Human Failing Myocardium. Biochemical and Biophysical Research Communications, 393, 55-60. https://doi.org/10.1016/j.bbrc.2010.01.076
|
[18]
|
Divorty, N., Milligan, G., Graham, D. and Nicklin, S.A. (2018) The Orphan Receptor GPR35 Contributes to Angiotensin II-Induced Hypertension and Cardiac Dysfunction in Mice. American Journal of Hypertension, 31, 1049-1058.
https://doi.org/10.1093/ajh/hpy073
|
[19]
|
Ronkainen, V.P., Tuomainen, T., Huusko, J., Laidinen, S., Malinen, M., Palvimo, J.J., et al. (2014) Hypoxia-Inducible Factor 1-Induced G Protein-Coupled Receptor 35 Expression Is an Early Marker of Progressive Cardiac Remodelling. Cardiovascular Research, 101, 69-77. https://doi.org/10.1093/cvr/cvt226
|
[20]
|
Chen, K., He, L., Li, Y., Li, X., Qiu, C., Pei, H., et al. (2020) Inhibition of GPR35 Preserves Mitochondrial Function After Myocardial Infarction by Targeting Calpain 1/2. Journal of Cardiovascular Pharmacology, 75, 556-563.
https://doi.org/10.1097/FJC.0000000000000819
|
[21]
|
Mccallum, J.E., Mackenzie, A.E., Divorty, N., Clarke, C., Delles, C., Milligan, G., et al. (2015) G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell Proliferation. Journal of Vascular Research, 52, 383-395. https://doi.org/10.1159/000444754
|
[22]
|
Coleman, J., Ngo, T., Smythe, R.E., Cleave, A.J., Jones, N.M., Graham, R.M., et al. (2020) The N-Terminus of GPR37L1 IS Proteolytically Processed by Matrix Metalloproteases. Scientific Reports, 10, Article No. 19995.
https://doi.org/10.1038/s41598-020-76384-9
|
[23]
|
Coleman, J.L.J., Mouat, M.A., Wu, J., Jancovski, N., Bassi, J.K., Chan, A.Y., et al. (2018) Orphan Receptor GPR37L1 Contributes to the Sexual Dimorphism of Central Cardiovascular Control. Biology of Sex Differences, 9, Article No. 14.
https://doi.org/10.1186/s13293-018-0173-y
|
[24]
|
Zheng, X., Asico, L.D., Ma, X. and Konkalmatt, P.R. (2019) G Protein-Coupled Receptor 37L1 Regulates Renal Sodium Transport and Blood Pressure. American Journal of Physiology-Renal Physiology, 316, F506-F516.
https://doi.org/10.1152/ajprenal.00289.2018
|